|
2025-04-14 |
2025-04-11 |
V
Verkauf
|
Cline Christopher R.
CHIEF FINANCIAL OFFICER
Führungsperson
|
1.000
-0.1%
13,14
631 USD
|
1.000
-0.1%
|
13,14
|
100.000 USD
|
|
|
2025-02-12 |
2025-02-12 |
GV
Geplanter Verkauf
|
ROTE WILLIAM E.
SENIOR VICE PRESIDENT, R&D
Führungsperson
|
5.200
-5.0%
23,53
122.356 USD
|
5.200
-5.0%
|
23,53
|
122.356 USD
|
|
|
2025-02-12 |
2025-02-12 |
GV
Geplanter Verkauf
|
REED ELIZABETH E
SVP, GC & CORPORATE SECRETARY
Führungsperson
|
8.000
-8.2%
23,53
188.240 USD
|
8.000
-8.2%
|
23,53
|
188.240 USD
|
|
|
2025-02-12 |
2025-02-12 |
V
Verkauf
|
Heerma Peter
CHIEF COMMERCIAL OFFICER
Führungsperson
|
2.568
-2.0%
23,53
60.426 USD
|
2.568
-2.0%
|
23,53
|
60.426 USD
|
|
|
2025-02-12 |
2025-02-12 |
V
Verkauf
|
Inrig Jula
CHIEF MEDICAL OFFICER
Führungsperson
|
2.568
-2.8%
23,53
60.426 USD
|
2.568
-2.8%
|
23,53
|
60.426 USD
|
|
|
2025-02-12 |
2025-02-11 |
GV
Geplanter Verkauf
|
Calvin Sandra
SVP, CHIEF ACCOUNTING OFFICER
Führungsperson
|
9.244
-14.5%
25,00
231.100 USD
|
9.244
-14.5%
|
25,00
|
231.100 USD
|
|
|
2025-02-12 |
2025-02-11 |
GV
Geplanter Verkauf
|
Calvin Sandra
SVP, CHIEF ACCOUNTING OFFICER
Führungsperson
|
15.000
-19.1%
25,00
375.000 USD
|
15.000
-19.1%
|
25,00
|
375.000 USD
|
|
|
2025-02-12 |
2025-02-11 |
GV
Geplanter Verkauf
|
Calvin Sandra
SVP, CHIEF ACCOUNTING OFFICER
Führungsperson
|
10.000
-13.6%
25,00
250.000 USD
|
10.000
-13.6%
|
25,00
|
250.000 USD
|
|
|
2025-02-12 |
2025-02-11 |
GV
Geplanter Verkauf
|
Calvin Sandra
SVP, CHIEF ACCOUNTING OFFICER
Führungsperson
|
10.000
-13.6%
25,00
250.000 USD
|
10.000
-13.6%
|
25,00
|
250.000 USD
|
|
|
2025-02-12 |
2025-02-11 |
GV
Geplanter Verkauf
|
Calvin Sandra
SVP, CHIEF ACCOUNTING OFFICER
Führungsperson
|
10.000
-13.6%
25,00
250.000 USD
|
10.000
-13.6%
|
25,00
|
250.000 USD
|
|
|
2025-02-12 |
2025-02-11 |
GV
Geplanter Verkauf
|
Heerma Peter
CHIEF COMMERCIAL OFFICER
Führungsperson
|
3.074
-2.4%
25,00
76.850 USD
|
3.074
-2.4%
|
25,00
|
76.850 USD
|
|
|
2025-02-12 |
2025-02-11 |
GV
Geplanter Verkauf
|
Dube Eric M
CHIEF EXECUTIVE OFFICER
Geschäftsführender Verwaltungsratsmitglied
|
11.375
-2.6%
24,04
273.455 USD
|
11.375
-2.6%
|
24,04
|
273.455 USD
|
|
|
2025-02-10 |
2025-02-06 |
GV
Geplanter Verkauf
|
Baynes Roy D.
Nicht geschäftsführender Verwaltungsratsmitglied
|
10.000
-24.4%
22,00
220.000 USD
|
10.000
-24.4%
|
22,00
|
220.000 USD
|
|
|
2025-02-04 |
2025-02-04 |
GV
Geplanter Verkauf
|
Inrig Jula
CHIEF MEDICAL OFFICER
Führungsperson
|
1.066
-1.3%
20,11
21.437 USD
|
1.066
-1.3%
|
20,11
|
21.437 USD
|
|
|
2025-02-04 |
2025-02-03 |
GV
Geplanter Verkauf
|
REED ELIZABETH E
SVP, GC & CORPORATE SECRETARY
Führungsperson
|
8.951
-9.1%
19,78
177.051 USD
|
8.951
-9.1%
|
19,78
|
177.051 USD
|
|
|
2025-02-04 |
2025-02-03 |
GV
Geplanter Verkauf
|
Dube Eric M
CHIEF EXECUTIVE OFFICER
Geschäftsführender Verwaltungsratsmitglied
|
50.691
-10.5%
20,21
1.024.343 USD
|
50.691
-10.5%
|
20,21
|
1.024.343 USD
|
|
|
2025-02-04 |
2025-02-03 |
GV
Geplanter Verkauf
|
ROTE WILLIAM E.
SENIOR VICE PRESIDENT, R&D
Führungsperson
|
8.951
-8.6%
19,78
177.051 USD
|
8.951
-8.6%
|
19,78
|
177.051 USD
|
|
|
2025-02-04 |
2025-02-03 |
V
Verkauf
|
Calvin Sandra
SVP, CHIEF ACCOUNTING OFFICER
Führungsperson
|
3.348
-5.0%
20,12
67.362 USD
|
3.348
-5.0%
|
20,12
|
67.362 USD
|
|
|
2025-02-04 |
2025-02-03 |
V
Verkauf
|
Inrig Jula
CHIEF MEDICAL OFFICER
Führungsperson
|
4.207
-4.7%
20,12
84.645 USD
|
4.207
-4.7%
|
20,12
|
84.645 USD
|
|
|
2025-02-04 |
2025-02-03 |
V
Verkauf
|
Heerma Peter
CHIEF COMMERCIAL OFFICER
Führungsperson
|
5.166
-4.0%
20,12
103.940 USD
|
5.166
-4.0%
|
20,12
|
103.940 USD
|
|
|
2025-02-04 |
2025-02-03 |
V
Verkauf
|
Cline Christopher R.
CHIEF FINANCIAL OFFICER
Führungsperson
|
5.192
-5.5%
20,12
104.463 USD
|
5.192
-5.5%
|
20,12
|
104.463 USD
|
|
|
2025-01-23 |
2025-01-23 |
GV
Geplanter Verkauf
|
Baynes Roy D.
Nicht geschäftsführender Verwaltungsratsmitglied
|
16.000
-34.0%
20,00
320.000 USD
|
16.000
-34.0%
|
20,00
|
320.000 USD
|
|
|
2025-01-23 |
2025-01-22 |
GV
Geplanter Verkauf
|
ROTE WILLIAM E.
SENIOR VICE PRESIDENT, R&D
Führungsperson
|
2.437
-2.8%
19,46
47.424 USD
|
2.437
-2.8%
|
19,46
|
47.424 USD
|
|
|
2025-01-23 |
2025-01-22 |
GV
Geplanter Verkauf
|
Dube Eric M
CHIEF EXECUTIVE OFFICER
Geschäftsführender Verwaltungsratsmitglied
|
10.736
-3.0%
19,46
208.923 USD
|
10.736
-3.0%
|
19,46
|
208.923 USD
|
|
|
2025-01-23 |
2025-01-22 |
V
Verkauf
|
Calvin Sandra
SVP, CHIEF ACCOUNTING OFFICER
Führungsperson
|
925
-1.7%
18,94
17.520 USD
|
925
-1.7%
|
18,94
|
17.520 USD
|
|
|
2025-01-23 |
2025-01-22 |
GV
Geplanter Verkauf
|
REED ELIZABETH E
SVP, GC & CORPORATE SECRETARY
Führungsperson
|
2.437
-3.1%
19,46
47.424 USD
|
2.437
-3.1%
|
19,46
|
47.424 USD
|
|
|
2025-01-23 |
2025-01-22 |
V
Verkauf
|
Cline Christopher R.
CHIEF FINANCIAL OFFICER
Führungsperson
|
865
-1.2%
18,94
16.384 USD
|
865
-1.2%
|
18,94
|
16.384 USD
|
|
|
2025-01-23 |
2025-01-22 |
V
Verkauf
|
Heerma Peter
CHIEF COMMERCIAL OFFICER
Führungsperson
|
1.584
-1.5%
18,94
30.002 USD
|
1.584
-1.5%
|
18,94
|
30.002 USD
|
|
|
2025-01-06 |
2025-01-06 |
GV
Geplanter Verkauf
|
Inrig Jula
CHIEF MEDICAL OFFICER
Führungsperson
|
440
-0.7%
18,76
8.254 USD
|
440
-0.7%
|
18,76
|
8.254 USD
|
|
|
2025-01-06 |
2025-01-03 |
V
Verkauf
|
Inrig Jula
CHIEF MEDICAL OFFICER
Führungsperson
|
2.066
-3.3%
19,10
39.461 USD
|
2.066
-3.3%
|
19,10
|
39.461 USD
|
|
|
2024-12-27 |
2024-12-26 |
GV
Geplanter Verkauf
|
Calvin Sandra
SVP, CHIEF ACCOUNTING OFFICER
Führungsperson
|
15.000
-21.5%
17,22
258.278 USD
|
15.000
-21.5%
|
17,22
|
258.278 USD
|
|
|
2024-11-25 |
2024-11-25 |
V
Verkauf
|
Calvin Sandra
SVP, CHIEF ACCOUNTING OFFICER
Führungsperson
|
12.090
-18.0%
18,30
221.258 USD
|
12.090
-18.0%
|
18,30
|
221.258 USD
|
|
|
2024-10-04 |
2024-10-04 |
GV
Geplanter Verkauf
|
LYONS GARY A
Nicht geschäftsführender Verwaltungsratsmitglied
|
18.821
-27.0%
15,15
285.227 USD
|
18.821
-27.0%
|
15,15
|
285.227 USD
|
|
|
2024-10-04 |
2024-10-04 |
GV
Geplanter Verkauf
|
LYONS GARY A
Nicht geschäftsführender Verwaltungsratsmitglied
|
21.179
-23.3%
14,35
303.874 USD
|
21.179
-23.3%
|
14,35
|
303.874 USD
|
|
|
2024-09-30 |
2024-09-30 |
GV
Geplanter Verkauf
|
Meckler Jeffrey A
Nicht geschäftsführender Verwaltungsratsmitglied
|
40.000
-33.1%
14,06
562.324 USD
|
40.000
-33.1%
|
14,06
|
562.324 USD
|
|
|
2024-09-10 |
2024-09-10 |
GV
Geplanter Verkauf
|
Inrig Jula
CHIEF MEDICAL OFFICER
Führungsperson
|
684
-1.1%
12,98
8.878 USD
|
684
-1.1%
|
12,98
|
8.878 USD
|
|
|
2024-09-09 |
2024-09-09 |
GV
Geplanter Verkauf
|
REED ELIZABETH E
SVP, GC & CORPORATE SECRETARY
Führungsperson
|
4.387
-5.3%
11,52
50.538 USD
|
4.387
-5.3%
|
11,52
|
50.538 USD
|
|
|
2024-09-09 |
2024-09-09 |
V
Verkauf
|
Inrig Jula
CHIEF MEDICAL OFFICER
Führungsperson
|
2.191
-3.4%
11,52
25.240 USD
|
2.191
-3.4%
|
11,52
|
25.240 USD
|
|
|
2024-09-09 |
2024-09-09 |
GV
Geplanter Verkauf
|
Dube Eric M
CHIEF EXECUTIVE OFFICER
Geschäftsführender Verwaltungsratsmitglied
|
21.125
-5.5%
11,52
243.360 USD
|
21.125
-5.5%
|
11,52
|
243.360 USD
|
|
|
2024-09-09 |
2024-09-09 |
V
Verkauf
|
Heerma Peter
CHIEF COMMERCIAL OFFICER
Führungsperson
|
2.191
-2.0%
11,52
25.240 USD
|
2.191
-2.0%
|
11,52
|
25.240 USD
|
|
|
2024-09-09 |
2024-09-09 |
GV
Geplanter Verkauf
|
ROTE WILLIAM E.
SENIOR VICE PRESIDENT, R&D
Führungsperson
|
4.387
-4.9%
11,52
50.538 USD
|
4.387
-4.9%
|
11,52
|
50.538 USD
|
|
|
2024-09-09 |
2024-09-09 |
V
Verkauf
|
Cline Christopher R.
CHIEF FINANCIAL OFFICER
Führungsperson
|
2.490
-3.2%
11,52
28.685 USD
|
2.490
-3.2%
|
11,52
|
28.685 USD
|
|
|
2024-09-05 |
2024-09-04 |
V
Verkauf
|
Cline Christopher R.
CHIEF FINANCIAL OFFICER
Führungsperson
|
514
-0.7%
9,51
4.888 USD
|
514
-0.7%
|
9,51
|
4.888 USD
|
|
|
2024-04-12 |
2024-04-11 |
V
Verkauf
|
Cline Christopher R.
CHIEF FINANCIAL OFFICER
Führungsperson
|
54
-0.1%
6,74
364 USD
|
54
-0.1%
|
6,74
|
364 USD
|
|
|
2024-02-02 |
2024-02-01 |
GV
Geplanter Verkauf
|
ROTE WILLIAM E.
SENIOR VICE PRESIDENT, R&D
Führungsperson
|
2.590
-3.1%
8,86
22.947 USD
|
2.590
-3.1%
|
8,86
|
22.947 USD
|
|
|
2024-02-02 |
2024-02-01 |
V
Verkauf
|
ROTE WILLIAM E.
SENIOR VICE PRESIDENT, R&D
Führungsperson
|
2.174
-2.5%
8,53
18.548 USD
|
2.174
-2.5%
|
8,53
|
18.548 USD
|
|
|
2024-02-02 |
2024-02-01 |
V
Verkauf
|
Heerma Peter
CHIEF COMMERCIAL OFFICER
Führungsperson
|
4.195
-4.0%
8,53
35.789 USD
|
4.195
-4.0%
|
8,53
|
35.789 USD
|
|
|
2024-02-02 |
2024-02-01 |
V
Verkauf
|
Cline Christopher R.
CHIEF FINANCIAL OFFICER
Führungsperson
|
3.818
-5.1%
8,53
32.573 USD
|
3.818
-5.1%
|
8,53
|
32.573 USD
|
|
|
2024-02-02 |
2024-02-01 |
GV
Geplanter Verkauf
|
REED ELIZABETH E
SVP, GC & CORPORATE SECRETARY
Führungsperson
|
2.590
-3.3%
8,86
22.947 USD
|
2.590
-3.3%
|
8,86
|
22.947 USD
|
|
|
2024-02-02 |
2024-02-01 |
V
Verkauf
|
REED ELIZABETH E
SVP, GC & CORPORATE SECRETARY
Führungsperson
|
2.174
-2.7%
8,53
18.548 USD
|
2.174
-2.7%
|
8,53
|
18.548 USD
|
|
|
2024-02-02 |
2024-02-01 |
V
Verkauf
|
Calvin Sandra
SVP, CHIEF ACCOUNTING OFFICER
Führungsperson
|
2.820
-5.1%
8,53
24.058 USD
|
2.820
-5.1%
|
8,53
|
24.058 USD
|
|
|
2024-02-02 |
2024-02-01 |
GV
Geplanter Verkauf
|
Dube Eric M
CHIEF EXECUTIVE OFFICER
Geschäftsführender Verwaltungsratsmitglied
|
10.016
-2.8%
8,86
88.742 USD
|
10.016
-2.8%
|
8,86
|
88.742 USD
|
|
|
2024-02-02 |
2024-02-01 |
V
Verkauf
|
Dube Eric M
CHIEF EXECUTIVE OFFICER
Geschäftsführender Verwaltungsratsmitglied
|
9.106
-2.5%
8,53
77.693 USD
|
9.106
-2.5%
|
8,53
|
77.693 USD
|
|
|
2024-02-02 |
2024-02-01 |
V
Verkauf
|
Inrig Jula
CHIEF MEDICAL OFFICER
Führungsperson
|
2.174
-3.6%
8,53
18.547 USD
|
2.174
-3.6%
|
8,53
|
18.547 USD
|
|
|
2024-01-25 |
2024-01-23 |
GV
Geplanter Verkauf
|
ROTE WILLIAM E.
SENIOR VICE PRESIDENT, R&D
Führungsperson
|
2.062
-3.3%
8,96
18.476 USD
|
2.062
-3.3%
|
8,96
|
18.476 USD
|
|
|
2024-01-25 |
2024-01-23 |
GV
Geplanter Verkauf
|
Dube Eric M
CHIEF EXECUTIVE OFFICER
Geschäftsführender Verwaltungsratsmitglied
|
7.873
-3.2%
8,96
70.542 USD
|
7.873
-3.2%
|
8,96
|
70.542 USD
|
|
|
2024-01-25 |
2024-01-23 |
GV
Geplanter Verkauf
|
REED ELIZABETH E
SVP, GC & CORPORATE SECRETARY
Führungsperson
|
2.062
-3.5%
8,96
18.476 USD
|
2.062
-3.5%
|
8,96
|
18.476 USD
|
|
|
2024-01-25 |
2024-01-23 |
V
Verkauf
|
Cline Christopher R.
CHIEF FINANCIAL OFFICER
Führungsperson
|
853
-1.7%
9,07
7.735 USD
|
853
-1.7%
|
9,07
|
7.735 USD
|
|
|
2024-01-25 |
2024-01-23 |
V
Verkauf
|
Heerma Peter
CHIEF COMMERCIAL OFFICER
Führungsperson
|
1.559
-1.9%
9,07
14.138 USD
|
1.559
-1.9%
|
9,07
|
14.138 USD
|
|
|
2024-01-25 |
2024-01-23 |
V
Verkauf
|
Calvin Sandra
SVP, CHIEF ACCOUNTING OFFICER
Führungsperson
|
910
-2.2%
9,07
8.252 USD
|
910
-2.2%
|
9,07
|
8.252 USD
|
|
|
2024-01-05 |
2024-01-04 |
GV
Geplanter Verkauf
|
Inrig Jula
Chief Medical Officer
Führungsperson
|
440
-1.2%
9,17
4.035 USD
|
440
-1.2%
|
9,17
|
4.035 USD
|
|
|
2024-01-05 |
2024-01-03 |
V
Verkauf
|
Inrig Jula
Chief Medical Officer
Führungsperson
|
2.069
-5.5%
9,48
19.613 USD
|
2.069
-5.5%
|
9,48
|
19.613 USD
|
|
|
2023-10-04 |
2023-10-03 |
V
Verkauf
|
Heerma Peter
Chief Commercial Officer
Führungsperson
|
3.091
-3.7%
8,25
25.504 USD
|
3.091
-3.7%
|
8,25
|
25.504 USD
|
|
|
2023-09-05 |
2023-09-05 |
GV
Geplanter Verkauf
|
Dube Eric M
Chief Executive Officer
Geschäftsführender Verwaltungsratsmitglied
|
4.455
-1.8%
14,71
65.533 USD
|
4.455
-1.8%
|
14,71
|
65.533 USD
|
|
|
2023-09-05 |
2023-09-05 |
V
Verkauf
|
Cline Christopher R.
Chief Financial Officer
Führungsperson
|
457
-0.9%
14,71
6.723 USD
|
457
-0.9%
|
14,71
|
6.723 USD
|
|
|
2023-09-05 |
2023-09-05 |
GV
Geplanter Verkauf
|
ROTE WILLIAM E.
Senior Vice President, R&D
Führungsperson
|
1.815
-2.9%
14,71
26.699 USD
|
1.815
-2.9%
|
14,71
|
26.699 USD
|
|
|
2023-09-05 |
2023-09-05 |
GV
Geplanter Verkauf
|
REED ELIZABETH E
SVP, GC & Corporate Secretary
Führungsperson
|
1.815
-3.0%
14,71
26.699 USD
|
1.815
-3.0%
|
14,71
|
26.699 USD
|
|
|
2023-05-12 |
2023-05-11 |
GV
Geplanter Verkauf
|
Calvin Sandra
SVP, Chief Accounting Officer
Führungsperson
|
122
-0.3%
16,12
1.967 USD
|
122
-0.3%
|
16,12
|
1.967 USD
|
|
|
2023-05-12 |
2023-05-10 |
GV
Geplanter Verkauf
|
ROTE WILLIAM E.
Senior Vice President, R&D
Führungsperson
|
825
-1.4%
16,59
13.687 USD
|
825
-1.4%
|
16,59
|
13.687 USD
|
|
|
2023-05-12 |
2023-05-10 |
V
Verkauf
|
Cline Christopher R.
Chief Financial Officer
Führungsperson
|
455
-0.9%
16,59
7.548 USD
|
455
-0.9%
|
16,59
|
7.548 USD
|
|
|
2023-05-12 |
2023-05-10 |
GV
Geplanter Verkauf
|
REED ELIZABETH E
SVP, GC & Corporate Secretary
Führungsperson
|
825
-1.4%
16,59
13.687 USD
|
825
-1.4%
|
16,59
|
13.687 USD
|
|
|
2023-05-12 |
2023-05-10 |
V
Verkauf
|
Calvin Sandra
SVP, Chief Accounting Officer
Führungsperson
|
436
-1.0%
16,59
7.233 USD
|
436
-1.0%
|
16,59
|
7.233 USD
|
|
|
2023-04-13 |
2023-04-11 |
V
Verkauf
|
Cline Christopher R.
Chief Financial Officer
Führungsperson
|
47
-0.1%
21,49
1.010 USD
|
47
-0.1%
|
21,49
|
1.010 USD
|
|
|
2023-02-02 |
2023-02-02 |
GV
Geplanter Verkauf
|
Calvin Sandra
SVP, Chief Accounting Officer
Führungsperson
|
360
-0.8%
22,42
8.071 USD
|
360
-0.8%
|
22,42
|
8.071 USD
|
|
|
2023-02-02 |
2023-02-01 |
GV
Geplanter Verkauf
|
Dube Eric M
Chief Executive Officer
Geschäftsführender Verwaltungsratsmitglied
|
8.196
-3.3%
22,25
182.361 USD
|
8.196
-3.3%
|
22,25
|
182.361 USD
|
|
